CURAXIS PHARMACEUTICAL CORP Financing Cash Flow
CURAXIS PHARMACEUTICAL CORP reported Financing Cash Flow of $89.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2012-05-14
- CURAXIS PHARMACEUTICAL CORP net cash provided by (used in) financing activities for the quarter ending 2012-03-31 was $89.00K, a 82.41% decline year-over-year.
- CURAXIS PHARMACEUTICAL CORP net cash provided by (used in) financing activities for the quarter ending 2011-12-31 was $97.00K.
- CURAXIS PHARMACEUTICAL CORP net cash provided by (used in) financing activities for the quarter ending 2011-09-30 was $170.00K, a 75.85% decline year-over-year.
- CURAXIS PHARMACEUTICAL CORP net cash provided by (used in) financing activities for the quarter ending 2011-06-30 was $104.00K.
- CURAXIS PHARMACEUTICAL CORP net cash provided by (used in) financing activities for fiscal 2011 was $877.00K, a 26.92% increase from fiscal 2010.
- CURAXIS PHARMACEUTICAL CORP net cash provided by (used in) financing activities for fiscal 2010 was $691.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 41 month | Net Cash Provided by (Used in) Financing Activities 127 month | Net Cash Provided by (Used in) Financing Activities 130 month | Net Cash Provided by (Used in) Financing Activities 133 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | $89.00K 10-Q · filed 2012-05-14 | $186.00K derived: sum of 2 quarters · filed 2012-05-14 | $356.00K derived: sum of 3 quarters · filed 2012-05-14 | $460.00K derived: sum of 4 quarters · filed 2012-05-14 | $80.48M 10-Q · filed 2012-05-14 | |||
| 2011-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $267.00K derived: sum of 2 quarters · filed 2012-03-29 | $371.00K derived: sum of 3 quarters · filed 2012-03-29 | $877.00K 10-K · filed 2012-03-29 | $80.39M 10-K · filed 2012-03-29 | |||
| 2011-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $274.00K derived: sum of 2 quarters · filed 2011-11-10 | $780.00K 10-Q · filed 2011-11-10 | $621.00K derived: sum of 4 quarters · filed 2012-05-14 | $80.29M 10-Q · filed 2011-11-10 | |||
| 2011-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-12 | $610.00K 10-Q · filed 2011-08-12 | $451.00K derived: sum of 3 quarters · filed 2012-05-14 | $1.16M derived: sum of 4 quarters · filed 2012-05-14 | $80.12M 10-Q · filed 2011-08-12 | |||
| 2011-03-31 | $506.00K 10-Q · filed 2012-05-14 | $347.00K derived: sum of 2 quarters · filed 2012-05-14 | $1.05M derived: sum of 3 quarters · filed 2012-05-14 | |||||
| 2010-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $545.00K derived: sum of 2 quarters · filed 2012-03-29 | $691.00K 10-K · filed 2012-03-29 | |||||
| 2010-09-30 | $704.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $850.00K 10-Q · filed 2011-11-10 | ||||||
| 2010-06-30 | $146.00K 10-Q · filed 2011-08-12 |